Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(Diaminomethyl-Methyl-Amino)-Acetic Acid is a synthetic small molecule with the molecular formula C4H11N3O2 and a molecular weight of approximately 133.15 g/mol[1][2][3][6]. It is classified as an alpha amino acid derivative, specifically related to glycine derivatives, and features both diaminomethyl and methylamino substituents on the acetic acid backbone[1][6]. The compound has been referenced in chemical databases such as PubChem (CID: 4635864) and DrugBank (DB02490), where it is listed as an experimental molecule with no current approved medical indications or clinical trial activity[6]. Its structure suggests potential for biochemical or pharmaceutical research applications, but there are no known marketed products or established therapeutic uses at this time[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (diaminomethyl-methyl-amino)-acetic acid.